OptiBiotix Health Plc (AIM:OPTI)

Market Cap	6.97M -56.9%
Revenue (ttm)	1.15M +102.3%
Net Income	-191.00K
EPS	-0.00
Shares Out	103.30M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	57,609
Average Volume	441,309
Open	6.80
Previous Close	6.75
Day's Range	6.80 - 7.00
52-Week Range	5.63 - 21.00
Beta	1.91
RSI	39.87
Earnings Date	Jun 16, 2026

About OptiBiotix Health

OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulation products in the United Kingdom, the United States, India, China, and internationally. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that can impact human physiology and derive potential health benefits. Its products include Slimbiome, which offers a scientifically supported, non-pharmaceutical approach to reduce hunger and cravings; C...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2006
• Employees: 10
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: OPTI

Financial Performance

In 2024, OptiBiotix Health's revenue was 870,000, an increase of 35.09% compared to the previous year's 644,000. Losses were -1.81 million, -11.48% less than in 2023.